Quantum Biopharma (QNTM) Receivables - Net (2018 - 2026)
Quantum Biopharma (QNTM) posted Receivables - Net of $208524.0 for Q1 2026, down 9.75% sequentially from $231053.0 in Q4 2025, and down 47.05% YoY from $393843.0 in Q1 2025.
Quantum Biopharma (QNTM) Receivables - Net (2018 - 2026) Analysis & Trends
Quantum Biopharma has reported Receivables - Net for 9 years, with the latest figure at $208524.0 in Q1 2026.
- Quarterly Receivables - Net fell 47.05% year-over-year to $208524.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $208524.0 (down 47.05% YoY) and the FY2025 annual result came in at $231053.0, down 38.33% from the prior year.
- Receivables - Net slipped to $208524.0 in Q1 2026 per QNTM's latest filing, from $231053.0 in the prior quarter.
- Over five years, Receivables - Net peaked at $393843.0 in Q1 2025 and troughed at $78300.0 in Q3 2025.
- A 5-year average of $227380.9 and a median of $218644.0 in 2023 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2025 and 2026: Receivables - Net soared 122.4% in 2025, then sank 47.05% in 2026.
- Over 5 years, Receivables - Net stood at $374377.0 in 2022, then slumped by 38.89% to $228764.0 in 2023, then surged by 63.78% to $374678.0 in 2024, then slumped by 38.33% to $231053.0 in 2025, then retreated by 9.75% to $208524.0 in 2026.
- According to Business Quant data, Receivables - Net over the past three periods registered $208524.0, $231053.0, and $78300.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.51 Bn | 78.51 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.74 Bn | 60.56 Bn | 1.37 Bn |
| 4 | Moderna | 59.39 Bn | 54.26 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.15 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.78 Bn | 28.47 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.65 Bn | 10.26 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.22 Bn | 26.39 Bn | - |
| 10 | Quantum Biopharma | 15.69 Mn | 12.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 107,634.00 |
| Jun 30, 2026 | 107,634.00 |
| Mar 31, 2026 | 208,524.00 |
| Mar 31, 2026 | 208,524.00 |
| Dec 31, 2025 | 231,053.00 |
| Dec 31, 2025 | 231,053.00 |
| Sep 30, 2025 | 78,300.00 |
| Sep 30, 2025 | 78,300.00 |
| Jun 30, 2025 | 193,198.00 |
| Jun 30, 2025 | 193,198.00 |
| Mar 31, 2025 | 393,843.00 |
| Mar 31, 2025 | 393,843.00 |
| Dec 31, 2024 | 374,678.00 |
| Dec 31, 2024 | 374,678.00 |
| Sep 30, 2024 | 104,204.00 |
| Sep 30, 2024 | 104,204.00 |
| Jun 30, 2024 | 86,868.00 |
| Jun 30, 2024 | 86,868.00 |
| Dec 31, 2023 | 228,764.00 |
| Dec 31, 2023 | 228,764.00 |